Fortress Biotech, Inc. financial data

Symbol
FBIO, FBIOP on Nasdaq
Industry
Pharmaceutical Preparations
Location
1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
CORONADO BIOSCIENCES INC (to 4/27/2015)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 130 % +5.12%
Quick Ratio 15.2 % +43.8%
Debt-to-equity 725 % -10.1%
Return On Equity 559 % -82%
Return On Assets -31.6 % +0.57%
Operating Margin -191 % -13.6%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 27.9M shares +84.9%
Entity Public Float 30.8M USD -41.8%
Common Stock, Value, Issued 28K USD +86.7%
Weighted Average Number of Shares Outstanding, Basic 20.8M shares +156%
Weighted Average Number of Shares Outstanding, Diluted 19.7M shares +163%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 57.7M USD -31.8%
Research and Development Expense 61M USD -52%
Costs and Expenses 168M USD -25.9%
Operating Income (Loss) -110M USD +22.5%
Nonoperating Income (Expense) -10.2M USD +9.98%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -26.6M USD -152%
Income Tax Expense (Benefit) 312K USD -40.1%
Net Income (Loss) Attributable to Parent -46M USD +24.1%
Earnings Per Share, Basic -2.69 USD/shares +68.2%
Earnings Per Share, Diluted -0.76 USD/shares +19.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 57.3M USD -29.2%
Accounts Receivable, after Allowance for Credit Loss, Current 10.2M USD -32.8%
Inventory, Net 14.4M USD +41.4%
Assets, Current 90.4M USD -22.8%
Property, Plant and Equipment, Net 3.26M USD -49.9%
Operating Lease, Right-of-Use Asset 13.9M USD -18.4%
Other Assets, Noncurrent 3.32M USD -22.6%
Assets 144M USD -13.9%
Accounts Payable, Current 31.6M USD -9.12%
Accrued Liabilities, Current 65.5M USD -11%
Liabilities, Current 71.4M USD -15.9%
Deferred Income Tax Liabilities, Net 233K USD
Operating Lease, Liability, Noncurrent 14.8M USD -19.3%
Other Liabilities, Noncurrent 1.76M USD -7.24%
Liabilities 146M USD -12.1%
Retained Earnings (Accumulated Deficit) -741M USD -6.62%
Stockholders' Equity Attributable to Parent 22.7M USD +0.86%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -1.64M USD -204%
Liabilities and Equity 144M USD -13.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.4M USD +41.3%
Net Cash Provided by (Used in) Financing Activities 27.9M USD +25.6%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 27.9M shares +84.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.47M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 58.8M USD -29.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.66M USD -42.5%
Deferred Tax Assets, Valuation Allowance 378M USD +3.16%
Deferred Tax Assets, Gross 385M USD +2.87%
Operating Lease, Liability 17.4M USD -16.5%
Depreciation 1.04M USD -53.4%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 20.8M USD -19.9%
Property, Plant and Equipment, Gross 15.4M USD -0.19%
Operating Lease, Liability, Current 2.62M USD +3.96%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.53M USD -6.93%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.54M USD -6.72%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.45M USD -33.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.27M USD -13.9%
Deferred Tax Assets, Operating Loss Carryforwards 233M USD +10.1%
Preferred Stock, Shares Issued 3.43M shares 0%
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 3.2M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.92M USD -17.3%
Operating Lease, Payments 920K USD +5.02%
Additional Paid in Capital 764M USD +6.44%
Preferred Stock, Shares Outstanding 3.43M shares 0%
Amortization of Intangible Assets 814K USD -23.9%
Deferred Tax Assets, Net of Valuation Allowance 6.66M USD -11.4%
Share-based Payment Arrangement, Expense 32.6M USD +91.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%